Pomdoctor Limited (POM)
NASDAQ: POM · Real-Time Price · USD
0.1213
+0.0035 (2.97%)
At close: May 19, 2026, 4:00 PM EDT
0.1104
-0.0109 (-8.99%)
After-hours: May 19, 2026, 7:16 PM EDT
Pomdoctor Revenue
In the year 2025, Pomdoctor had annual revenue of 399.92M CNY with 16.74% growth. Pomdoctor had revenue of 225.45M in the half year ending December 31, 2025, with 27.35% growth.
Revenue (ttm)
399.92M CNY
Revenue Growth
+16.74%
P/S Ratio
0.25
Revenue / Employee
2,563,558 CNY
Employees
156
Market Cap
14.37M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 399.92M | 57.36M | 16.74% |
| Dec 31, 2024 | 342.56M | 37.71M | 12.37% |
| Dec 31, 2023 | 304.85M | 59.64M | 24.32% |
| Dec 31, 2022 | 245.22M | 29.83M | 13.85% |
| Dec 31, 2021 | 215.39M | 74.18M | 52.53% |
| Dec 31, 2020 | 141.21M | -44.33M | -23.89% |
| Dec 31, 2019 | 185.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 449.71B |
| Johnson & Johnson | 96.36B |
| Eli Lilly and Company | 72.25B |
| AbbVie | 62.82B |
| Bionano Genomics | 28.74M |
| Cyclerion Therapeutics | 1.99M |
| CytoMed Therapeutics | 669.28K |
| Vyome Holdings | 152.72K |
POM News
- 5 days ago - POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results - PRNewsWire
- 2 months ago - POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management - PRNewsWire
- 3 months ago - POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities - PRNewsWire
- 3 months ago - PomDoctor receives noncompliance notification from Nasdaq - TheFly
- 3 months ago - POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice - PRNewsWire
- 4 months ago - POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies - PRNewsWire
- 5 months ago - POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results - PRNewsWire
- 7 months ago - Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program - Business Wire